General Inception

”Transforming gene therapy with an advanced AAV delivery platform“ KU Leuven's Trellis Research Group, headed by Prof. Dr. Els Henckaerts, developed an innovative process that equips rAAV vectors with molecules that accurately target them towards their intended locations. This advancement enables more efficient delivery and can help future rAAV gene therapies to have fewer side effects Co-founded with General Inception, KU-LRD and Gemma Frisius Fund in 2023,Tavira Therapeutics is currently in the process of securing additional funding in order to expand the initial proof of principle, grow the team, and ultimately deliver a more efficient and effective therapeutic solution to patients. The appointment of Bob Smith as an independent Chairman further bolsters the already robust team at Tavira. Wishing all the best to Tavira !!! #Tavira Therapeutcs #KU Leuven LRD #Bob Smith

GI launches Igniter Europe !!!! We are delighted to announce that General Inception (GI) is expanding its presence in Europe with the launch of Igniter Europe! This exciting development would not have been possible without the exceptional contributions of our team on both sides of the Atlantic, as well as the support of some of the world's top investors and institutions (#Bpifrance, #KU Leuven, #Paladin Capital Group, in addition to our existing set of investors (Genoa Ventures, OMX Ventures, Northpond Ventures, Paladin Capital Group, Hughes Management Group). We are thrilled to embark on this new venture and are committed to delivering the same level of excellence that our cofounders have come to expect from us to our new cofounders in Europe. Igniter Europe has launched with a portfolio that includes Abbelight, Ennovate Pharma, GauDDi, Nickl Tx, and Tavira Tx. In the future, we plan to support many more scientific founders and deep tech companies in the fields of Therapeutics, Life Science Tools, and Engineered Biology. #GeneralInception #Igniter #deeptech #lifescience #venture Francois Valencony, Venkat Reddy, Paul Conley, Vikram Chaudhery, Pierre GILLET, Océane Fleury, Mourad Yesayan

Illuminate a GI portfolio company with cutting-edge technology: an innovative drug delivery system designed to specifically target tumors, effectively tackling the challenges of safety faced in cancer treatment. Proud to be partnering with Prof. Hayes to bring this technology to patients. #generalinception #illuminate

We are thrilled to have SimBioSys, Inc. as our partner in our pursuit of delivering more effective, personalized cancer therapies! What a great day for patients, physicians and the healthcare system! #illuminate, #Nickl

We are so proud to support Greg Timblin and #InaPill team in their quest to develop therapeutics addressing immunometabolism in multitude of diseases.

Don't miss General Inception Co-Founder, Vikram Chaudhery, at the Arizona BioPreneur Conference on March 15th! #Startup #Igniter #entrepreneur #growth #venturecaptial

The convergence of biology & technology is transforming the healthcare industry and opening new frontiers. Mark Lehmkuhle, Founder & CEO of Genoa Ventures’ portfolio company Epitel, published an informative overview of how this convergence trend is transforming Neuroscience.

🚀 Unveiling "Ignition Time," a new podcast presented by General Inception! 🚀 Ignite your entrepreneurial spirit as we delve into company creation and successful scaling. Join us as we engage in conversations with scientific trailblazers, seasoned executives, successful entrepreneurs, and visionary venture capital investors. Explore the journey of transformative ideas evolving into thriving companies. In our debut episode, we are thrilled to feature our dynamic Co-Founders, Paul Conley, CEO, and Vikram Chaudhery, COO and President. Dive into the genesis of General Inception as Paul recounts his growth from academia to business, sharing the pivotal moments that shaped his vision. Gain insights into the passion that fueled Paul's desire to be the kind of VC he wished he had as an entrepreneur. Uncover the essence of our igniter model principles, propelling General Inception beyond the ordinary VC experience. Hear anecdotes from their experiences with difficulties that arise from starting up and why the igniter model is a fundamentally different environment for starting a new business. This isn't just a podcast; it's a journey into the heart of entrepreneurial excellence. Embark on this transformative experience now! 🎧 Listen to the full episode on Spotify: https://lnkd.in/erY9g_KS #venturecapital #startup #partnership #growth #Ignitiontime

🚨 NEW WEBINAR 🚨 📅 Wednesday, February 7, 2024 | 🕛 12:00pm ET | 📝 https://lnkd.in/dUjJudtu Our first webinar of the new year is coming up next month! We are excited to host Deborah Palestrant of 5AM Ventures, Jay Lichter of Avalon BioVentures, and Vikram Chaudhery of General Inception as they describe their fund thesis, what they look for in opportunities arising from academic institutions, and the process of their company formation efforts.